Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03713125 · ClinicalTrials.gov registry record · NA

Executive Function in Early Childhood

A NA study of Reading Disability, sponsored by Vanderbilt University.

Recruiting
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT03713125 is a NA study of Reading Disability that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 260 participants, roughly in line with the 247-participant average among 4 other Reading Disability trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03713125, a NA study of Reading Disability, is actively recruiting participants, sponsored by Vanderbilt University.

RECRUITING
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

Despite the fact that a substantial number of school age children struggle with both reading and math acquisition, the brain mechanisms of the overlapping aspects of reading and math skills, thought in part to be linked via executive functions (EF), have not been unpacked. This project will use a longitudinal design, following children from Kindergarten through 1st grade, to understand how the brain networks associated with reading, math, and EF interact to predict academic outcomes and, in those who struggle academically, intervention response.

Conditions Studied

Interventions

  • BEHAVIORAL Reading Tutoring

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2019-08-13
Est. Completion 2026-07-31
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT03713125

The ClinicalTrials.gov registry entry for NCT03713125 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 247-participant average among 4 other Reading Disability trials with a reported enrollment target. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Reading Disability appearing as the primary indexed condition, and to 1 intervention - of which Reading Tutoring is the first listed.

NCT03713125 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03713125 about?

NCT03713125 is a clinical study titled "Executive Function in Early Childhood". Despite the fact that a substantial number of school age children struggle with both reading and math acquisition, the brain mechanisms of the overlapping aspects of reading and math skills, thought in part to be linked via executive functions (EF), have not been unpacked. This project will use a lo...

What is the current status of trial NCT03713125?

This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2019-08-13. Estimated completion is 2026-07-31.

What conditions does trial NCT03713125 study?

This clinical trial studies the following conditions: Reading Disability.

What interventions are being tested in trial NCT03713125?

The interventions under investigation include: Reading Tutoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT03713125?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03713125 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Reading Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.